The global vaccine CDMO market is set to witness a growth rate of 8% in the next 5 years. Increasing demand for vaccines, ...

A study of over 280,000 adults found that the shingles vaccine reduced dementia risk by 20%, with a stronger effect in women.

Analysis of a Welsh program offering live-attenuated shingles vaccines to people born after a certain date showed a 20 percent relative drop in dementia risk.

It’s difficult to predict what this year’s flu season is going to be like. But it’s a good time to start thinking about ...

The strongest set of evidence to date indicates that people who had a shingles vaccine had significantly lower odds of ...

A recent study found that people who received Zostavax, a older shingles vaccine, had a lower risk of developing dementia.

Two important contributors of early protection are speed of replication and onset of immunity, according to Alberto Giner, ...

This new system will aid researchers in developing vaccines and in studying the ... synthetic DNA to replicate and assemble into new virus particles. This process results in the production of live ...

Oncolytic adenovirus was engineered for the forced ectopic delivery of peptide-MHC ligand of T cell receptors (TCRs) to ...

A new study out of Stanford has presented the strongest evidence to date that a common vaccine could significantly reduce the ...

Researchers from the J. Craig Venter Institute (JCVI), the Friedrich-Loeffler-Institut (FLI), and the International Livestock ...